Lite Strategy (LITS) Gross Margin Growth (3y) (2019 - 2021)
Lite Strategy (LITS) Gross Margin Growth (3y) (2019 - 2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -230.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -168.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | -65.00 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 14,836.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 589.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 53.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -3,244.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 569.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Lite Strategy | 35.71 Mn | 28.17 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 4,924.00 |
| Sep 30, 2021 | 20,266.00 |
| Jun 30, 2021 | 20,201.00 |
| Mar 31, 2021 | 20,979.00 |
| Dec 31, 2020 | 19,943.00 |
| Sep 30, 2020 | 21,071.00 |
| Jun 30, 2020 | 21,815.00 |
| Mar 31, 2020 | -4,367.00 |
| Dec 31, 2019 | -5,329.00 |
| Sep 30, 2019 | 4,035.00 |